Replies to post #693258 on NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

I agree the IA likely did not disclose the actual PFS results at the time. But they would have provided an opinion on halting the trial early and for what reason. Whatever they might have said would be an issue. Even if they said to continue as normal that tells NWBO that there was not sufficiently good results to halt for efficacy,.

Of course we all know what the result if the IA actually was. The DSMB saw that PFS was failed. Does not matter it failed, it did. And knowing that NWBO changed the endpoint.

And before you say we don;t know the DSMB called the primary futile, BS. We all know the actual PFS results and treatment did well worse. The DSMB would have seen that, They called it futile. The FDA halted screening of new patients,.